Oral sustained release compositions of latrepirdine for the treatment of neurodegenerative diseases, and especially Alzheimer's disease (AD) and Huntington's disease, are disclosed herein. Also provided are process for their manufacture.
申请公布号
WO2011039686(A1)
申请公布日期
2011.04.07
申请号
WO2010IB54309
申请日期
2010.09.24
申请人
PFIZER INC.;BARTLETT, JEREMY ADAM;CURATOLO, WILLIAM JOHN;ZIEGLER, JR., CARL BERNARD
发明人
BARTLETT, JEREMY ADAM;CURATOLO, WILLIAM JOHN;ZIEGLER, JR., CARL BERNARD
